Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5

  1. Rothenberg, M.E.
  2. Roufosse, F.
  3. Faguer, S.
  4. Gleich, G.J.
  5. Steinfeld, J.
  6. Yancey, S.W.
  7. Mavropoulou, E.
  8. Kwon, N.
  9. García, G.R.
  10. Sosso, A.
  11. Wehbe, L.
  12. Yañez, A.
  13. Blockmans, D.
  14. Antila, M.A.
  15. Blanco, D.
  16. Grava, S.
  17. Lima, M.A.
  18. Francisco Pez, A.L.
  19. Hamidou, M.A.
  20. Kahn, J.-E.
  21. Lefévre, G.
  22. Brockow, K.
  23. Kern, P.M.
  24. Reiter, A.J.
  25. Walz, B.
  26. Welte, T.
  27. Pane, F.
  28. Vannucchi, A.M.
  29. Cerino-Javier, R.
  30. Gazca-Aguilar, A.
  31. Hernández-Colín, D.D.
  32. Valdéz-López, H.G.
  33. Kupryś-Lipińska, I.R.
  34. Musial, J.
  35. Prejzner, W.
  36. Mihaly, E.
  37. Popov, V.
  38. Zdrenghea, M.T.
  39. Gritsaev, S.V.
  40. Ivanov, V.
  41. Tsyba, N.
  42. Alonso, A.
  43. Cid Xutgla, M.C.
  44. Fox, M.L.
  45. Delgado, R.G.
  46. Hernández Rivas, J.M.
  47. Santillana, G.S.
  48. González, A.I.
  49. Wardlaw, A.J.
  50. Akuthota, P.
  51. Butterfield, J.H.
  52. Chupp, G.L.
  53. Cox, J.B.
  54. Jhaveri, D.
  55. Show all authors +
Journal:
Journal of Allergy and Clinical Immunology: In Practice

ISSN: 2213-2198

Year of publication: 2022

Volume: 10

Issue: 9

Pages: 2367-2374.e3

Type: Article

DOI: 10.1016/J.JAIP.2022.04.037 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals